Life ScienceCompany
MorphoSys M&A Summary
MorphoSys has acquired 3 companies of its own, including 1 in the last 5 years. It has also divested 1 asset.
MorphoSys’ largest acquisition to date was in 2021, when it acquired Constellation Pharmaceuticals for $1.7B. It’s largest disclosed sale occurred in 2013, when it sold AbD Serotec to Bio-Rad Laboratories for $60M. MorphoSys has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (67%) and information technology (34%).
MorphoSys Ownership
Who owns MorphoSys?
MorphoSys is owned by Novartis AG. It was acquired on February 5, 2024.
MorphoSys Business Overview
Where is MorphoSys headquartered?
MorphoSys is headquartered in Planegg, Germany.
What is MorphoSys’ revenue?
MorphoSys disclosed revenue of 278M EUR for 2022 and 180M EUR for 2021.
What sector is MorphoSys in?
MorphoSys is a life science company.
When was MorphoSys founded?
MorphoSys was founded in 1992.
M&A Summary
-
M&A Total Activity4
- M&A Buy Activity3
- M&A Sell Activity1
- Total Sectors Invested 2
- Total Countries Invested 2
- M&A Buy/Sell Connections 2
- M&A Advisors 2
Unlimited Searches
